Similar Stories to Elan, Biogen Change Terms Of Tysabri Collaboration on Bing News

Biogen Idec will take over full ownership of the multiple sclerosis treatment Tysabri from its partner Irish drugmaker Elan Corp. PLC in exchange for a $3.25 billion cash payment and royalties…

Topics:  biogen idec   tysabri   irish   elan   corp   change   
BING NEWS:
  • Biogen Inc. (BIIB) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
    Great. Good morning, everyone. Thank you so much for joining us. Really pleased to have the Biogen team here with us. We have Alisha Alaimo who's the President, Head of North America; and Chuck Triano ...
    06/12/2024 - 8:20 am | View Link
  • Biogen executive plays down looming competition for its Alzheimer's drug
    Biogen's Alzheimer's drug, Leqembi, will do well in the market whether a competitor comes or not, a company executive said at the Goldman Sachs Global Healthcare Conference on Wednesday. Leqembi, ...
    06/12/2024 - 6:18 am | View Link
  • Buy Rating for Biogen Justified by Competitive Edge and FDA Insights on Safety Profiles
    It offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, VUMERITY, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of ...
    06/9/2024 - 4:35 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News